Source - SMW
Motif Bio said a subsidiary had reached agreement with its former clinical research organisation to settle all obligations without further payment.

The pact would result in the reversal of a previously-recognised expense and the reduction of trade payables and accruals by $2.4m.

This payable and accrual was shown in the year-end 2018 and interim financials.




Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.